Cloning & Expression Vectors Explained | Recombinant Protein Tech

Added:

Recombinant Proteins
Vector Design Basics
Recombinant DNA History
Founding Discoveries
Biotech Industry Rise
Plasmid Vector Features
Plasmid Vector Generations
Advanced Cloning Vectors
Large-Insert Vectors
Expression Systems

Recombinant Proteins

0:00
Playing Section
  • 1

    Lecture introduces recombinant protein production for human benefit.

  • 2

    Focus is on designing cloning and expression vectors for various hosts.

  • 3

    Knowledge of gene regulation enables protein expression across species.

The Central Dogma of Molecular Biology, specifically the mechanisms of DNA transcription and mRNA translation into proteins.
Basic structure and function of plasmid DNA in bacteria, including how plasmids replicate autonomously.
The function of key molecular biology enzymes, particularly restriction endonucleases (restriction enzymes) and DNA ligase.
Concepts of bacterial transformation and selection markers, such as antibiotic resistance genes.
Selecting and optimizing host expression systems, comparing prokaryotic (e.g., E. coli) versus eukaryotic (e.g., yeast, mammalian, or insect cells) systems.
Recombinant protein purification methodologies, such as affinity chromatography using vector-encoded fusion tags (e.g., His-tag, GST-tag).
Industrial bioprocess scale-up, including bioreactor design, optimizing protein yield, and downstream processing.
Advanced therapeutic applications of recombinant proteins, such as the manufacture of monoclonal antibodies, vaccines, and hormone therapies like insulin.
18.3K views164likes57:42@iitOriginal Release: 2011-09-27

Cloning and expression vectors are engineered DNA molecules that enable the introduction and expression of specific genes in host cells to produce recombinant proteins. Expression vectors contain regulatory elements such as promoters and enhancers that drive high-level transcription of inserted genes, allowing the production of therapeutic proteins like insulin, growth hormone, and interferon in microbial and mammalian expression systems. The development of these vectors, pioneered by researchers like Paul Berg, Stanley Cohen, and Herbert Boyer in the 1970s, laid the foundation for the multi-billion dollar biotechnology industry, enabling the production of over 160 approved biotech drugs that have helped more than 325 million people worldwide.